Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-44
Sildenafil
Cat. No.
AKA-44
CAS No.
139755-83-2
MF
C22H30N6O4S
MW
474.6
Sildenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
Sildenafil
CAS No.
139755-83-2
MF
C22H30N6O4S
MW
474.6
Specification
99%
Description
Sildenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor. Packing: 1kg/bag; 25kg/drum or as request
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Wang Z, et al. The Selectivity and Potency of the New PDE5 Inhibitor TPN729MA. The Journal of Sexual Medicine. 2013 Nov;10(11):2790-7. PMID: 23937247
[2]. Li BB, et al. Sildenafil potentiates the proliferative effect of porcine pulmonary artery smooth muscle cells induced by serotonin in vitro. Chin Med J (Engl). 2011 Sep;124(17):2733-40. PMID: 22040433
[3]. Moretti R, et al. Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain. Journal of Neuroinflammation. 2016 Apr 28;13(1):95. PMID: 27126393
[4]. Korkmaz MF, et al. The Effect of Sildenafil on Recuperation from Sciatic Nerve Injury in Rats. Balkan Medical Journal. 2016 Mar;33(2):204-11. PMID: 27403391
[2]. Li BB, et al. Sildenafil potentiates the proliferative effect of porcine pulmonary artery smooth muscle cells induced by serotonin in vitro. Chin Med J (Engl). 2011 Sep;124(17):2733-40. PMID: 22040433
[3]. Moretti R, et al. Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain. Journal of Neuroinflammation. 2016 Apr 28;13(1):95. PMID: 27126393
[4]. Korkmaz MF, et al. The Effect of Sildenafil on Recuperation from Sciatic Nerve Injury in Rats. Balkan Medical Journal. 2016 Mar;33(2):204-11. PMID: 27403391
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
AKA-373
Abietic acid
CAS No.:514-10-3
MF:C20H30O2
AKA-372
Dipexion™ Fmoc-Val-Ser(psi(Me,Me)pro)-OH
CAS No.:186023-49-4
MF:C26H30N2O6
AKA-371
Dipexion™ Fmoc-Gly-Ser(psi(Me,Me)pro)-OH
CAS No.:1095952-22-9
MF:C23H24N2O6
AKA-370
Oxymatrine
CAS No.:16837-52-8
MF:C15H24N2O2
AKA-369
Matrine
CAS No.:519-02-8
MF:C15H24N2O
AKA-368
Dipexion™ Fmoc-Lys（Boc）-Thr[PSI(Me,Me)Pro]-OH
CAS No.:911838-56-7
MF:C33H43N3O8
AKA-367
Dipexion™ Fmoc-Leu-Ser[PSI(Me,Me)Pro]-OH
CAS No.:339531-50-9
MF:C27H32N2O6
AKA-366
Dipexion™ Fmoc-Ser(tBu)-Thr[PSI(Me,Me)Pro]-OH
CAS No.:1266350-99-5
MF:C29H36N2O7
AKA-365
Dipexion™ Fmoc-Glu(OtBu)-Thr[PSI(Me,Me)Pro]-OH
CAS No.:957780-56-2
MF:C31H38N2O8
AKA-364
Dipexion™ Fmoc-Lys（Boc）-Ser[PSI(Me,Me)Pro]-OH
CAS No.:957780-54-0
MF:C32H41N3O8
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
